The story of Viagra presents a challenging picture for shareholders. While the initial launch generated substantial gains, the end of its intellectual property protection opened the avenue to generic versions, https://bookmarkstime.com/story22343244/sildenafil-and-the-pharmaceutical-industry-a-precarious-investment